Skip to content
GenoLensGenoLens

IDUA

Chr 4p16.3

alpha-L-iduronidase

Aliases:
MPS1, MPSI
MANE:
ENST00000514224.2

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Lysosomal storage disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Mucopolysaccharideosis, Gaucher, Fabry

    BIALLELIC, autosomal or pseudoautosomal
  • Mucopolysaccharidosis type IH or S

    BIALLELIC, autosomal or pseudoautosomal
  • Paediatric or syndromic cardiomyopathy

    BIALLELIC, autosomal or pseudoautosomal

+6 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • Hurler syndrome

    0.85
  • Scheie syndrome

    0.85
  • Hurler-Scheie syndrome

    0.85
  • mucopolysaccharidosis type 1

    0.81
  • mucopolysaccharidosis

    0.70
  • hereditary disease

    0.51
  • nephrolithiasis susceptibility caused by SLC26A1

    0.50
  • nephrolithiasis, calcium oxalate

    0.46
  • calcium oxalate urolithiasis

    0.46
  • bone fracture

    0.45

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Alpha-L-iduronidase

Lysosomal hydrolase responsible for the degradation of the glycosaminoglycans heparan sulfate and dermatan sulfate

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.